Revivo Therapeutics is a clinical stage biotechnology company based in the United States that is spearheading the development of a new class of drugs targeting cognitive decline. With their pioneering approach, their first drug candidate, RIV-5061, aims to address the treatment of Mild Cognitive Impairment. Currently, the company is in the process of raising funding for Phase 1/1b clinical trials.
Revivo Therapeutics
Clinical stage biotechnology company with a new class of drugs targteting cognitive decline
Founded 2016
Durham, United States
5 employees
Health Care
Durham, United States
5 employees
Health Care
General Information
Company Name
Revivo Therapeutics
Founded Year
2016
Location
Durham, United States
Durham, United States
Employees
5
Industries
Health Care
BounceWatch is an independent company data service, not affiliated with Revivo Therapeutics. To contact Revivo Therapeutics, visit revivotherapeutics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Health Care
About Revivo Therapeutics
Taxonomy: clinical stage, drug development, cognitive decline, small molecules, Mild Cognitive Impairment, Phase 1/1b trials, neuroscience, pharmaceuticals, cognitive enhancement
No funding data available for Revivo Therapeutics yet.
Revivo Therapeutics Alternatives & Competitors
Revivo Therapeutics vs
Bionure
Spain
Clinical stage biotech developing new drugs for CNS diseases.
Series A
8 employees
Biotechnology, Health Care
Revivo Therapeutics vs
Taiwan's Leading New Drug Developer In Dermatology & Neurology
18 employees
Biotechnology, Health Care
Revivo Therapeutics vs
FAQ About Revivo Therapeutics
Clinical stage biotechnology company with a new class of drugs targteting cognitive decline
Revivo Therapeutics was founded in 2016.
Revivo Therapeutics is headquartered in Durham, United States.
Revivo Therapeutics operates in Health Care. Its work centres on clinical stage, drug development, cognitive decline and small molecules.
Revivo Therapeutics has approximately 5 employees.
Top alternatives and competitors to Revivo Therapeutics include Bionure, AnnJi Pharmaceutical Co., Ltd., Atom Therapeutics, Treadwell Therapeutics, Inc., Cognition Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Revivo Therapeutics and Bionure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Revivo Therapeutics, https://bouncewatch.com/company/revivo-therapeutics, updated 10 October 2024. When citing, please name BounceWatch and link this page.
